Ge Long Hui·2026-01-23 10:37Core Viewpoint - Jiangzhong Pharmaceutical reported its preliminary unaudited financial data for the year ending December 31, 2025, indicating a focus on brand building and core business consolidation amid structural industry adjustments [1] Financial Performance - For the year 2025, Jiangzhong Pharmaceutical achieved a revenue of RMB 4.22 billion, representing a year-on-year decline of 4.87% [1] - The net profit attributable to shareholders of the listed company was RMB 906 million, showing a year-on-year increase of 14.96% [1] Strategic Initiatives - The company is enhancing its marketing strategies, optimizing cost structures, and deepening lean manufacturing practices to improve profitability [1] - Jiangzhong Pharmaceutical is focusing on "big single products and strong categories" to solidify its core business foundation [1]